Skip to main content
Premium Trial:

Request an Annual Quote

FDA Grants Emergency Use Authorization for Trax Management Coronavirus Test

NEW YORK — The US Food and Drug Administration on Monday granted Emergency Use Authorization for Trax Management Services' PCR-based SARS-CoV-2 test.

According to the FDA, the PhoenixDx 2019-CoV test is designed to detect SARS-CoV-2 E and RDRP genes in nasal, nasopharyngeal, and oropharyngeal swabs, as well as bronchoalveolar lavage specimens. It runs on any authorized RT-PCR instrument and can be performed by labs CLIA-certified to perform high-complexity tests.

The test was developed by Thalgau, Austria-based Procomcure Biotech. Lewis Center, Ohio-based Trax sources pharmaceutical and medical products.

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.